US Dry Powdered Inhaler Market Competitive Analysis by end user industries & Forecast to 2025

The US dry powdered inhaler market is anticipated to grow at a substantial rate of around 1.2% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of dry powdered inhaler market in the US. Further, the increasing demand for inhaler due to increasing COPD and asthma patients in the US has endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US the major market in the North American region due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases.

Get Sample Copy of US Dry Powdered Inhaler Market at: https://www.omrglobal.com/request-sample/us-dry-powdered-inhaler-market

The major players of the US inhaler market include 3M Co., AstraZeneca PLC, Aradigm Corp., Adherium Ltd., GlaxoSmithKline PLC, Novartis AG, ResMed Corp. (Propeller Health), Teva Pharmaceuticals Industries Ltd.

The US dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

For More Information get A full report of US Dry Powdered Inhaler is available at: https://www.omrglobal.com/industry-reports/us-dry-powdered-inhaler-market

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing dry powdered inhalers to cater to a wide range of customers within the region and across the globe. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

US Dry Powdered Inhaler Market Segmentation

US Dry Powdered Inhaler Market by Type

• Preventive Dry Powdered Inhaler
• Reliever Dry Powdered Inhaler
• Long Acting Bronchodilators Dry Powdered Inhaler

US Dry Powdered Inhaler Market by Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

US Dry Powdered Inhaler Market by End-User

• Homecare
• Hospitals and Clinics

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-dry-powdered-inhaler-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.